Aiforia as an investment

Strategy and targets

Strategy

Aiforia aims to revolutionize pathology with AI to provide better care for every patient. The company's vision is to be the global leader in AI-powered pathology image analysis.  

Aiforia’s growth is supported by megatrends such as rising rates of cancer and chronic diseases, aging populations, and personalized healthcare, which are driving up sample volumes at a time when certain geographic areas are experiencing a shortage of pathologists.

Strategic focus areas

GROWTH

Invest in sales, marketing, and support services in the US, Europe, and other key markets to enable strong growth. Scale the business by acquiring new customers, increasing sales within individual accounts, and establishing key strategic partnerships.

PRODUCT

Invest in R&D to strengthen our competitive advantage (AI-driven workflow, transparency, a versatile portfolio, and security) and continue developing features to further improve the customer experience. Adopt new regulatory frameworks in key markets.

PEOPLE

Invest in people management to improve employee experience and personnel productivity. Leverage our purpose-driven culture to attract and retain top-tier talent.

Business targets

Aiforia does not publish short-term outlooks or financial targets. However, the company has set medium-term business targets: 

Aiforia’s mid-term business targets:

  • Achieve financial independence by the end of 2027
  • Create a product offering that covers 80 percent of the pathologist’s diagnostic workflow (2030)
  • Achieve 50 key accounts (potential for over EUR 500 thousand in annual recurring revenue) (2030)
  • Leverage technology beyond diagnostic support for pathologists (2030).

Megatrends

AI transformation

Cloud adaptation in healthcare

Aging population

Personalized healthcare

Rising healthcare costs

Shortage of pathologists

Business model

Read about our business model

Management team

Get to know our Management team members